Stock Price Quote

FREDUN PHARMACEUTICALS LTD.

NSE : NABSE : 539730ISIN CODE : INE194R01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE717.30-4.95 (-0.69 %)
PREV CLOSE ( ) 722.25
OPEN PRICE ( ) 736.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 17411
TODAY'S LOW / HIGH ( )695.00 745.00
52 WK LOW / HIGH ( ) 6501249
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 08-06 1987
Management Info
Daulat N Medhora - Chairman Fredun N Medhora - Managing Director
Registered Office

Address 11th Floor, Tower A,Urmi Estate 95, Ganpatrao Kadam Marg,Lower Parel (W),
Mumbai,
Maharashtra-400013

Phone 022-40318111

Email business@fredungroup.com

Website www.fredungroup.com

Registrars Details
Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
Listing : BSE

NEWS

22Mar Allotment of Convertible warrants
Preferential Issue of shares Inter alia, pursuant to the approval of Sh..
22Mar Allotment of Equity Shares
Preferential Issue of shares Inter alia, pursuant to the approval of Sh..
12Feb Fredun Pharmaceuticals gets orders wor
Fredun Pharmaceuticals has received large orders from Southeast Asian (S..
12Feb Fredun Pharmaceuticals informs about p
Fredun Pharmaceuticals has informed that it enclosed press release title..
19Jan Fredun Pharmaceuticals informs about v
Fredun Pharmaceuticals has informed that it enclosed the Voting Results..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit42.2100000000001108.07
Gross Profit 57.6300000000001 175.09
Operating Profit 105.15296
Net Sales 870.082764.98

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  26946.00 (0.74%)
M.Cap ( in Cr)57258.37
Sanofi India (BSE)
peergroup  8118.25 (2.06%)
M.Cap ( in Cr)18696.83
Dr. Reddy's Lab (BSE)
peergroup  6155.15 (1.78%)
M.Cap ( in Cr)102679.14
Divi's Lab (BSE)
peergroup  3436.75 (2.14%)
M.Cap ( in Cr)91234.91
Glaxosmithkline Phar (BSE)
peergroup  1943.10 (3.26%)
M.Cap ( in Cr)32917.29

Shareholding Pattern

NON-INSTITUTION 49.25%
PROMOTERS 49.16%
FI/BANKS/INSURANCE 1.6%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Fredun Pharmaceuticals Ltd.

Fredun Pharmaceuticals Ltd. was incorporated in the year 1987. Its today's share price is 717.3. Its current market capitalisation stands at Rs 337.25 Cr. In the latest quarter, company has reported Gross Sales of Rs. 2746.76 Cr and Total Income of Rs.2765.19 Cr. The company's management includes Daisy Cyril Dsouz, Jinkal Soni, Rohinton H Kanga, Nariman B Medhora, Aspi N Raimalwala, Fredun N Medhora, Daulat N Medhora, Daulat N Medhora.

It is listed on the BSE with a BSE Code of 539730 , NSE with an NSE Symbol of and ISIN of INE194R01017. It's Registered office is at 11th Floor, Tower A,Urmi Estate 95, Ganpatrao Kadam Marg,Lower Parel (W)Mumbai-400013, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Salve & Co, Savla & Associates, VD Kandekar & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.